5-Fluorouracil (5-FU) is an essential component of systemic chemotherapy for colorectal
cancer (CRC) in the palliative and adjuvant settings. Over the past four decades, several …

New non-invasive approaches that can complement and improve on current strategies for
colorectal cancer (CRC) screening and management are urgently needed. A growing number …

Accurate colorectal cancer (CRC) risk prediction models are critical for identifying individuals
at low and high risk of developing CRC, as they can then be offered targeted screening …

There is a strong demand for the identification of new biomarkers in colorectal cancer (CRC)
diagnosis. Among all liquid biopsy analysts, cell-free circulating DNA (cfDNA) is probably …

Background & Aims Human studies examining associations between circulating levels of
insulin-like growth factor 1 (IGF1) and insulin-like growth factor binding protein 3 (IGFBP3) and …

Colorectal cancer (CRC) remains a serious health problem worldwide. Approximately half
of patients will develop distant metastasis after CRC resection, usually with very poor …

Objective An understanding of the etiologic heterogeneity of colorectal cancer (CRC) is critical
for improving precision prevention, including individualized screening recommendations …

Background And Aims Susceptibility genes and the underlying mechanisms for the majority
of risk loci identified by genome-wide association studies (GWAS) for colorectal cancer (CRC…

Colorectal cancer (CRC) is a malignant disease with an incidence of over 1.8 million new
cases per year worldwide. CRC outcome is closely related to the respective stage of CRC and …

Metastasis Associated Lung Adenocarcinoma Transcript 1 (MALAT1), originally described
as a prognostic biomarker remarkably linked with metastasis potential in lung cancer, has …